Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.89 |
| ▸ | CA4 | P22748 | 3/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | THPO | P40225 | 1/20 | 0.46 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.46 |
| ▸ | LCK | P06239 | 1/20 | 0.46 |
| ▸ | FYN | P06241 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.42 |
| ▸ | FAHD1 | Q6P587 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.36 |
| ▸ | MMP12 | P39900 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL196205 | 1.00 | — | — | |
| Acetic Acid SCHEMBL1168762 | 0.95 | CA1 (0.80) | CA1CA4LMNATSHRTHPO | |
| Acetic Acid SCHEMBL28703302 | 0.95 | CA1 (0.80) | CA1CA4LMNATSHRTHPO | |
| Acetic Acid SCHEMBL27279038 | 0.91 | CA1 (0.73) | CA1CA4LMNATSHRTHPO | |
| Acetic Acid SCHEMBL3711688 | 0.91 | — | — | |
| Acetic Acid SCHEMBL1168096 | 0.91 | CA1 (0.73) | CA1CA4LMNATSHRTHPO | |
| Acetic Acid SCHEMBL9117998 | 0.89 | CA1 (0.89) | CA1CA4LMNATSHRTHPO | |
| Acetic Acid SCHEMBL140294 | 0.89 | — | — | |
| Acetic Acid SCHEMBL119187 | 0.89 | CA1 (0.89) | CA1CA4LMNATSHRTHPO | |
| Acetic Acid SCHEMBL135062 | 0.89 | CA1 (0.89) | CA1CA4LMNATSHRTHPO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 366 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260036897-A1 | REPAIR PROCESS FOR CLEAR DEFECTS ON EUV PSM MASKS | ZEISS CARL SMT GMBH (DE) | 2026-02-05 | — | — | US | claimed |
| WO-2025061949-A2 | METHOD AND DEVICE FOR MASK REPAIR | CARL ZEISS SMT GMBH (DE) | 2025-03-27 | — | — | WO | claimed |
| CN-119215982-A | Catalyst for co-production of dimethyl carbonate and monomethyl malonate, and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-12-31 | — | — | CN | claimed |
| WO-2024223530-A1 | REPAIR PROCESS FOR CLEAR DEFECTS ON EUV PSM MASKS | CARL ZEISS SMT GMBH (DE) | 2024-10-31 | — | — | WO | claimed |
| EP-3195932-B1 | HYDROSILYLATION REACTION CATALYST | UNIV KYUSHU NAT UNIV CORP (JP) | 2024-08-21 | — | — | EP | claimed |
| CN-116514621-B | Method for constructing C-C bond at ortho-position of aryl by metal-catalyzed sulfur ylide and aryl sulfur/selenoacetic acid ester rearrangement reaction | 四川大学 | 2024-04-09 | — | — | CN | claimed |
| CN-117679340-A | Anti-aging composition containing epidermal growth factor and preparation method and application thereof | 湖南湘妃医疗器械有限公司 | 2024-03-12 | — | — | CN | claimed |
| CN-117164497-A | Synthesis method of pyrrole-2-ketone compound | 华南理工大学 | 2023-12-05 | — | — | CN | claimed |
| CN-113443970-B | Synthesis method of 4-alkoxy phenol compound | 新乡医学院 | 2023-04-07 | — | — | CN | claimed |
| CN-110483272-B | Novel method for asymmetric synthesis of (1S,2S) -2-fluorocyclopropanecarboxylic acid by catalysis of chiral rhodium catalyst | 广州康瑞泰药业有限公司 | 2022-09-27 | — | — | CN | claimed |
| CN-109400629-B | Indole spirooxazine heterocyclic compound and preparation method thereof | 江西师范大学 | 2022-07-12 | — | — | CN | claimed |
| CN-114433239-A | Rhodium nanoparticle dispersion and preparation method and application thereof | 中国石油化工股份有限公司 | 2022-05-06 | — | — | CN | claimed |
| CN-113582993-B | Condensed polycyclic compound containing triazahydronaphthalene structure and preparation method and application thereof | 广州大学 | 2022-04-19 | — | — | CN | claimed |
| EP-4748840-A1 | IMIDAZO[1,2-A]PYRIDINE TYPE IRAK DEGRADATION AGENT AND USE THEREOF | TAINUORUI (TIANJIN) BIOTECHNOLOGY CO., LTD (CN) | 2026-05-27 | — | — | EP | disclosed |
| EP-4747253-A1 | SPIROCYCLIC WRN HELICASE INHIBITORS | Merck Sharp & Dohme LLC (US) | 2026-05-27 | — | — | EP | disclosed |
| CN-116768861-B | SOS1 protein degradation targeting chimeric and composition, preparation and application thereof | 北京福元医药股份有限公司 | 2026-05-12 | — | — | CN | disclosed |
| WO-2000059854-A1 | METHOD FOR PRODUCING ALKAPOLYENYL COMPOUNDS USING CERTAIN COCATALYSTS | BASF AKTIENGESELLSCHAFT (DE) | 2000-10-12 | — | — | WO | disclosed |
| WO-2000018759-A1 | PHENYLALANINE DERIVATIVES AS ALPHA 4 INTEGRIN INHIBITORS | CELLTECH THERAPEUTICS LIMITED (GB) | 2000-04-06 | — | — | WO | disclosed |
| WO-1995016686-A1 | HETEROARYL MUPIROCIN DERIVATIVES USEFUL AS ANTIBACTERIAL, ANTIFUNGAL OR HERBICIDAL AGENTS | SMITHKLINE BEECHAM PLC (GB) | 1995-06-22 | — | — | WO | disclosed |
| US-4535169-A | 5H-6-oxo-2,3,4,4a,7,7a-hexahydropyrano[2,3-b]pyrrole and the preparation thereof | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 1985-08-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260036897-A1 | REPAIR PROCESS FOR CLEAR DEFECTS ON EUV PSM MASKS | PML, MUS81, PSMD14 | CA1 3642/4885CA4 2440/4885LMNA 584/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.